Bid is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| BH3 Interacting Domain Death Agonist | |
|---|---|
| Gene Symbol | BID |
| Full Name | BH3 Interacting Domain Death Agonist |
| Chromosome | 22q11.21 |
| NCBI Gene ID | 637 |
| OMIM | 603678 |
| Ensembl ID | ENSG00000105619 |
| UniProt ID | P55957 |
| Associated Diseases | Stroke, Alzheimer's Disease, Liver Disease |
BID (BH3 Interacting Domain Death Agonist) is a pro-apoptotic BCL2 family protein that serves as a critical link between extrinsic and intrinsic apoptosis pathways. As a BH3-only protein, BID contains a single BH3 domain that enables it to interact with both pro-survival BCL2 proteins and the executioner proteins BAX and BAK1. Upon cleavage by caspase-8, truncated BID (tBID) translocates to mitochondria where it promotes cytochrome c release, amplifying the apoptotic signal. In neurons, BID-mediated apoptosis contributes to neurodegenerative processes following stroke, traumatic brain injury, and chronic neurodegenerative diseases.
BID (BH3 Interacting Domain Death Agonist) is a pro-apoptotic BCL2 family protein with a unique mechanism of action. Full-length BID is relatively inactive, but it can be cleaved by caspases (particularly caspase-8) to generate truncated BID (tBID), which translocates to mitochondria and promotes apoptosis. tBID functions as a BH3-only protein that can both neutralize anti-apoptotic BCL2 proteins and directly activate BAX and BAK1. BID serves as a link between extrinsic (death receptor) and intrinsic (mitochondrial) apoptosis pathways.
BID is expressed in many tissues including brain. In the nervous system, BID cleavage contributes to neuronal apoptosis in response to various stimuli including excitotoxicity, oxidative stress, and ischemic injury.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Stroke | Activated | Acquired | Ischemic neuronal death |
| Alzheimer's Disease | May contribute | Acquired | Amyloid-induced apoptosis |
| Liver Disease | Mutations | Autosomal recessive | Hepatocyte apoptosis |
The study of Bid has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.